Biotech Roche to Acquire Televant for $7.1 Billion
- October 27, 2023
Swiss pharmaceutical manufacturer Roche plans to acquire Telavant Holdings, Inc. for $7.1 billion upfront and a near-time milestone payment of $150 million under a definitive agreement announced October 23.
ARTICLE TAGS
You must be logged in to access this content.